GCG and diabetes mellitus: A short treatment course of exendin-4, a long-acting glucagon-like peptide-1 (GLP-1) analogue, in the newborn period reverses epigenetic modifications at the proximal promoter of Pdx1 and prevents the development of diabetes in IUGR rats [7,19].